(Q51571077)

7 April 2018

title

Matrix metalloproteinase-12 gene regulation by a PPAR alpha agonist in human monocyte-derived macrophages. (English)

1 reference

7 April 2018

author name string

Imen Jguirim Souissi

1

1 reference

7 April 2018

Ludivine Billiet

2

1 reference

7 April 2018

Clarisse Cuaz-Pérolin

3

1 reference

7 April 2018

Mohamed-Naceur Slimane

4

1 reference

7 April 2018

Mustapha Rouis

5

1 reference

7 April 2018

language of work or name

English

0 references

publication date

18 September 2008

1 reference

7 April 2018

Experimental Cell Research

published in

1 reference

7 April 2018

volume

314

1 reference

7 April 2018

issue

18

1 reference

7 April 2018

page(s)

3405-3414

1 reference

7 April 2018

Atherosclerosis — An Inflammatory Disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Atherosclerotic plaque caps are locally weakened when macrophages density is increased

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Matrix metalloproteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Metalloproteinases and their inhibitors in matrix remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Matrix metalloproteinases: a tail of a frog that became a prince

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Expression of tissue inhibitor of metalloproteinases-3 in human atheroma and regulation in lesion-associated cells: a potential protective mechanism in plaque stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Mouse macrophage elastase. Purification and characterization as a metalloproteinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Apolipoprotein E knockout mice over-expressing human tissue inhibitor of metalloproteinase 1 are protected against aneurysm formation but not against atherosclerotic plaque development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Expression and localization of matrix metalloproteinase-12 in the aorta of cholesterol-fed rabbits: relationship to lesion development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Macrophage metalloelastase accelerates the progression of atherosclerosis in transgenic rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Induction and regulation of matrix metalloproteinase-12 by cytokines and CD40 signaling in monocyte/macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Transforming growth factor-beta 1 inhibits cytokine-mediated induction of human metalloelastase in macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Plasma metalloproteinase-12 and tissue inhibitor of metalloproteinase-1 levels and presence, severity, and outcome of coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Transcriptional repression of atherogenic inflammation: modulation by PPARdelta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Mechanism of action of fibrates on lipid and lipoprotein metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Reciprocal regulation of inflammation and lipid metabolism by liver X receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

The PPARs: from orphan receptors to drug discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Differential responses of PPARalpha, PPARdelta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Development of selective inhibitors and substrate of matrix metalloproteinase-12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Peroxisome proliferator-activated receptor alpha induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Overexpression of human matrix metalloproteinase-12 enhances the development of inflammatory arthritis in transgenic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Association of increased expression of macrophage elastase (matrix metalloproteinase 12) with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

The regulation of AP-1 activity by mitogen-activated protein kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Transcription factor interactions: selectors of positive or negative regulation from a single DNA element.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Ligand-activated retinoic acid receptor inhibits AP-1 transactivation by disrupting c-Jun/c-Fos dimerization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Phosphorylation of c-jun mediated by MAP kinases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Activation of cAMP and mitogen responsive genes relies on a common nuclear factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

Macrophage-specific overexpression of human matrix metalloproteinase-12 in transgenic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.09.002

10.1016/J.YEXCR.2008.09.002

7 January 2021

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018